Dermatologicals in Mexico
DERMATOLOGICALS IN MEXICO
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Paediatric Dermatologicals Shows Dynamism
Antifungals Remains the Largest Category
Competitive Landscape
Genomma Lab Internacional and Bayer De México Lead Dermatologicals
Lomecan V Continues To Strengthen Its Competitive Positioning in Vaginal Antifungals
Private Label's Potential for Growth
Category Data
Table 1 Sales of Dermatologicals by Category: Value 2013-2018
Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018
Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018
Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2015-2018
Table 6 Forecast Sales of Dermatologicals by Category: Value 2018-2023
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023
Executive Summary
Demographics, Innovation and Retailing Development Support Consumer Health Growth
Convenience and Multi-benefits Drive Innovation in Consumer Health
Despite Losing Share Over the Review Period, Herbalife Remains the Leader
Internet Retailing Growth Observed in Consumer Health Categories
the Forecast Period's Best Performances Will Be Driven by Wellness Concerns
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018
Market Data
Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Distribution of Consumer Health by Format: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format and Category: % Value 2018
Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Sources
Summary 1 Research Sources
Paediatric dermatologicals includes products designed specifically to treat children’s skin ailments, such as skin allergies, atopic dermatitis, or any other skin irritation. Compañía Internacional de Comercio and Laboratorios Expanscience México lead category. The first is the local subsidiary of Taisho Pharmaceutical Holdings Co Ltd and owns the brand Vitacilina Bebé. Although Vitacilina Bebé is commonly used as a nappy (diaper) rash treatment, its formulation is aimed at also treating other t...
Euromonitor International's Dermatologicals in Mexico report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.